EZH2 and colorectal carcinoma: Many studies have demonstrated that the mRNA and protein expression of EZH2 is significantly increased in CRC tissues compared with adjacent noncancerous tissues, and that EZH2 overexpression is closely associated with reduced OS and disease-free survival (DFS)[63, 64].